FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220710977> ?p ?o ?g. }

• W4220710977 endingPage "1459" @default.
• W4220710977 startingPage "1442" @default.
• W4220710977 abstract "Muscle loss alone, or in the context of sarcopenia or cachexia, is a prevalent condition and a predictor of negative outcomes in aging and disease. As adequate nutrition is essential for muscle maintenance, a growing number of studies has been conducted to explore the role of specific nutrients on muscle mass or function. Nonetheless, more research is needed to guide evidence-based recommendations. This scoping review aimed to compile and document ongoing clinical trials investigating nutrition interventions as a strategy to prevent or treat low muscle mass or function (strength and physical performance), sarcopenia, or cachexia. ClinicalTrials.gov and the WHO International Clinical Trials Registry Platform were searched up to 21 April 2021 for planned and ongoing trials. Randomized controlled trials with ≥20 participants per arm were included based on intent to explore the effects of nutrition interventions on muscle-related outcomes (i.e. muscle mass or strength, physical performance, or muscle synthesis rate) in both clinical and non-clinical conditions (i.e. aging). Two reviewers independently screened records for eligibility, and a descriptive synthesis of trials characteristics was conducted. A total of 113 trials were included in the review. Most trials (69.0%) enroll adults with clinical conditions, such as cancer (19.5%), obesity and metabolic diseases (16.8%), and musculoskeletal diseases (10.7%). The effects of nutrition interventions on age-related muscle loss are explored in 31% of trials. Although nutrition interventions of varied types were identified, food supplements alone (48.7%) or combined with dietary advice (11.5%) are most frequently reported. Protein (17.7%), amino acids (10.6%), and β-hydroxy-β-methylbutyrate (HMB, 6.2%) are the top three food supplements' nutrients under investigation. Primary outcome of most trials (54.9%) consists of measures of muscle mass alone or in combination with muscle strength and/or performance (as either primary or secondary outcomes). Muscle strength and physical performance are primary outcomes of 38% and 31.9% of the trials, respectively. These measurements were obtained using a variety of techniques. Only a few trials evaluate muscle synthesis rate either as a primary or secondary outcome (5.3%). Several nutrition studies focusing on muscle, sarcopenia, and cachexia are underway and can inform future research in this area. Although many trials have similar type of interventions, methodological heterogeneity may challenge study comparisons, and future meta-analyses aiming to provide evidence-based recommendations. Upcoming research in this area may benefit from guidelines for the assessment of therapeutic effects of nutrition interventions." @default.
• W4220710977 created "2022-04-03" @default.
• W4220710977 creator A5015245314 @default.
• W4220710977 creator A5024382995 @default.
• W4220710977 creator A5031316687 @default.
• W4220710977 creator A5048218365 @default.
• W4220710977 creator A5052526023 @default.
• W4220710977 creator A5067779580 @default.
• W4220710977 creator A5073729099 @default.
• W4220710977 creator A5090948585 @default.
• W4220710977 date "2022-03-17" @default.
• W4220710977 modified "2023-10-01" @default.
• W4220710977 title "Mapping ongoing nutrition intervention trials in muscle, sarcopenia, and cachexia: a scoping review of future research" @default.
• W4220710977 cites W1478139227 @default.
• W4220710977 cites W1655617308 @default.
• W4220710977 cites W1970350518 @default.
• W4220710977 cites W1970952704 @default.
• W4220710977 cites W2003064100 @default.
• W4220710977 cites W2006175454 @default.
• W4220710977 cites W2029230411 @default.
• W4220710977 cites W2039735127 @default.
• W4220710977 cites W2063690006 @default.
• W4220710977 cites W2070014351 @default.
• W4220710977 cites W2101713668 @default.
• W4220710977 cites W2103520707 @default.
• W4220710977 cites W2108696783 @default.
• W4220710977 cites W2116294028 @default.
• W4220710977 cites W2120673540 @default.
• W4220710977 cites W2121853412 @default.
• W4220710977 cites W2127226434 @default.
• W4220710977 cites W2127424726 @default.
• W4220710977 cites W2127908702 @default.
• W4220710977 cites W2132273917 @default.
• W4220710977 cites W2145280166 @default.
• W4220710977 cites W2154042628 @default.
• W4220710977 cites W2158539135 @default.
• W4220710977 cites W2159880697 @default.
• W4220710977 cites W2164059021 @default.
• W4220710977 cites W2164186760 @default.
• W4220710977 cites W2165707746 @default.
• W4220710977 cites W2166056254 @default.
• W4220710977 cites W2167013734 @default.
• W4220710977 cites W2172570273 @default.
• W4220710977 cites W2214973932 @default.
• W4220710977 cites W2257285672 @default.
• W4220710977 cites W2406325431 @default.
• W4220710977 cites W2505149831 @default.
• W4220710977 cites W2521019952 @default.
• W4220710977 cites W2593764183 @default.
• W4220710977 cites W2612183129 @default.
• W4220710977 cites W2735943180 @default.
• W4220710977 cites W2736187061 @default.
• W4220710977 cites W2747357561 @default.
• W4220710977 cites W2766252417 @default.
• W4220710977 cites W2791409969 @default.
• W4220710977 cites W2791498037 @default.
• W4220710977 cites W2795119888 @default.
• W4220710977 cites W2802374582 @default.
• W4220710977 cites W2806596191 @default.
• W4220710977 cites W2809202362 @default.
• W4220710977 cites W2883885422 @default.
• W4220710977 cites W2884687693 @default.
• W4220710977 cites W2889388367 @default.
• W4220710977 cites W2891378911 @default.
• W4220710977 cites W2897513125 @default.
• W4220710977 cites W2909344099 @default.
• W4220710977 cites W2914618904 @default.
• W4220710977 cites W2939244924 @default.
• W4220710977 cites W2965328845 @default.
• W4220710977 cites W2972352663 @default.
• W4220710977 cites W2974171230 @default.
• W4220710977 cites W2985413827 @default.
• W4220710977 cites W2990615003 @default.
• W4220710977 cites W2991498934 @default.
• W4220710977 cites W3000072669 @default.
• W4220710977 cites W3005437800 @default.
• W4220710977 cites W3008473611 @default.
• W4220710977 cites W3014318556 @default.
• W4220710977 cites W3019409866 @default.
• W4220710977 cites W3030753538 @default.
• W4220710977 cites W3042245479 @default.
• W4220710977 cites W3048385253 @default.
• W4220710977 cites W3092081291 @default.
• W4220710977 cites W3093516840 @default.
• W4220710977 cites W3103104242 @default.
• W4220710977 cites W3105749561 @default.
• W4220710977 cites W3108657423 @default.
• W4220710977 cites W3116545475 @default.
• W4220710977 cites W3117385140 @default.
• W4220710977 cites W3118615836 @default.
• W4220710977 cites W3127975826 @default.
• W4220710977 cites W3134066514 @default.
• W4220710977 cites W3134877230 @default.
• W4220710977 cites W3136465602 @default.
• W4220710977 cites W3137172831 @default.
• W4220710977 cites W3157451471 @default.
• W4220710977 cites W3163269558 @default.
• W4220710977 cites W3165672236 @default.

• next